Astrazeneca is too big and complex to base its CEO's pay on the rest of the FTSE index, according to the chair of its ...

The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million ...

The Financial Times top stories include a UK watchdog's provisional approval of a $570 million travel deal, AstraZeneca ...

AstraZeneca has been hit with a US class action lawsuit that claims the UK’s largest listed company misled shareholders in connection with investigations by Chinese authorities.

Pascal Soriot (pictured) topped up his basic salary of £1.8m with extras that included a bonus of £3.5m and share awards ...

Bold visions of tall buildings, upscale restaurants, luxury apartments and architectural marvels were proposed. So how is ...

Net Sales at Rs 440.29 crore in December 2024 up 43.98% from Rs. 305.79 crore in December 2023. Quarterly Net Profit at Rs.

UBS Group upgraded shares of AstraZeneca (NASDAQ:AZN – Free Report) from a neutral rating to a buy rating in a research note ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

AstraZeneca (AZN) has reported positive results from an analysis of its NIAGARA Phase 3 study of Imfinzi in the treatment of ...

AstraZeneca’s ( www.AstraZeneca.com) flagship health equity programme - Healthy Heart Africa (HHA), marks its 10th ...